ArticleFrontiers in oncology2025

Real-world data analysis of adjuvant capecitabine for triple-negative breast cancer after neoadjuvant chemotherapy.

Ana Godoy-Ortíz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.